Glucose lowering treatments and cardiovascular risk

被引：0
|
作者：
Bonnet, F. [1 ]
机构：
[1] Hop Sud, Serv Endocrinol Diabetol Nutr, Rennes, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2010年 / 14卷 / 09期
关键词：
Cardiovascular; Glucose lowering treatment; Diabetes; MYOCARDIAL-INFARCTION; MORTALITY; OUTCOMES; SULFONYLUREAS; PIOGLITAZONE; DISEASE; TRIAL;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 284
页数：4
相关论文
共 50 条
  • [21] Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
    Patti, Angelo Maria
    Rizvi, Ali A.
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Ligi, Daniela
    Mannello, Ferdinando
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [22] Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
    Rozalina G. McCoy
    Jeph Herrin
    Kavya Sindhu Swarna
    Yihong Deng
    David M. Kent
    Joseph S. Ross
    Guillermo E. Umpierrez
    Rodolfo J. Galindo
    William H. Crown
    Bijan J. Borah
    Victor M. Montori
    Juan P. Brito
    Joshua J. Neumiller
    Mindy M. Mickelson
    Eric C. Polley
    Nature Cardiovascular Research, 2024, 3 : 431 - 440
  • [23] Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
    Mccoy, Rozalina G.
    Herrin, Jeph
    Swarna, Kavya Sindhu
    Deng, Yihong
    Kent, David M.
    Ross, Joseph S.
    Umpierrez, Guillermo E.
    Galindo, Rodolfo J.
    Crown, William H.
    Borah, Bijan J.
    Montori, Victor M.
    Brito, Juan P.
    Neumiller, Joshua J.
    Mickelson, Mindy M.
    Polley, Eric C.
    NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (04): : 431 - 440
  • [24] Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments
    W. Ryan Powell
    Cindy L. Christiansen
    Donald R. Miller
    Diabetes Therapy, 2018, 9 : 1431 - 1440
  • [25] Meta-Analysis of Sulfonylurea Therapy on Long-Term Risk of Mortality and Cardiovascular Events Compared to Other Oral Glucose-Lowering Treatments
    Powell, W. Ryan
    Christiansen, Cindy L.
    Miller, Donald R.
    DIABETES THERAPY, 2018, 9 (04) : 1431 - 1440
  • [26] Blood pressure lowering and cardiovascular risk
    Stoner, Lee
    Wu, Brian
    LANCET, 2014, 384 (9956): : 1746 - 1746
  • [27] Diabetes Management - Lowering Cardiovascular Risk
    Gaita, Dan
    Mosteoru, Svetlana
    Sperling, Laurence
    EUROPEAN CARDIOLOGY REVIEW, 2014, 9 (01) : 7 - 9
  • [28] RA—lowering cardiovascular risk with statins
    Justin M. S. Lee
    Robin P. Choudhury
    Nature Reviews Rheumatology, 2010, 6 : 123 - 124
  • [29] EFFECTS OF GLUCOSE LOWERING DRUGS ON CARDIOVASCULAR RISK IN TYPE 2 DIABETES MELLITUS: REALITIES AND PERSPECTIVES
    Kobalava, Zh D.
    Kiyakbaev, G. K.
    KARDIOLOGIYA, 2018, 58 (01) : 53 - 65
  • [30] PPARγ stimulation improves cardiovascular risk profile independent from its glucose lowering effects
    Hohberg, C
    Lübben, G
    Forst, T
    Marx, N
    Weber, MM
    Löbig, M
    Pfützner, A
    DIABETES, 2005, 54 : A149 - A150
12345